Bayer AG recently proposed a $2 billion compensation cap for future claims against its product Roundup. Plaintiffs have accused Bayer of causing cancer via the popular weedkiller used by farmers and home gardeners.
Founded in 1863, the German-based multinational pharmaceutical and life sciences company is one of the world's largest pharmaceutical firms, with aspirin its most famous creation.
Roundup has been under scrutiny for safety issues since 2018 when Bayer purchased Monsanto Co., the famous weed killer manufacturer. Bayer has been battling court cases ever since in courts brought by sick plaintiffs.
Plaintiffs’ lawyers requested a compensation program of between $5000 and $200,000 for future claimants who contract non-Hodgkin lymphoma after using Roundup. The American Cancer Society describes non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma), as “cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system.”
Since lymphoma affects the body’s lymph system, it is often fatal. 20,720 people will die from non-Hodgkin lymphoma this year from this form of cancer.
In California, Bayer agreed in June 2020 to pay $9.6 billion to settle multiple existing Roundup cases, including sick plaintiffs, but still denies any link between the weed killer and cancer.
However, the 2020 agreement did not apply to any future lawsuits. With more cases still being filed, the new deal by Bayer would apply to any plaintiffs who have not yet filed a claim with an attorney.
At first, the total payout agreement was at $1.3 billion, but Bayer added another $750,000 to bring the total payout number to $2 billion.
The new Bayer pre-emptive payout is available to anyone in the future who claims Roundup caused their non-Hodgkin lymphoma. Claimants can apply to participate in the new settlement. Each plaintiff will receive part of the compensation depending upon their illness, age, proof of Roundup usage, and more.
The settlement fund lasts four years and is renewable. Individuals may also sue Bayer on their own, separate and beyond the class action lawsuit.
Currently, Roundup is available in stores worldwide. Under the new agreement, Bayer would include a link on each label to a website with information about glyphosate, the chemical used in Roundup linked to cancer.
A study in Science Direct reports people using the weedkiller with glyphosate will have a forty-one percent higher risk of non-Hodgkin lymphoma.
3M has agreed to pay $7.35 billion to settle lawsuits involving as many as 120,000 people who allege that toxic chemicals in firefighting foam caused cancer and other serious illnesses.The company announced the agreement Tuesday, November 3, 2026, saying it would resolve approximately 99% of existing personal injury claims involving... Read More about 3M to Pay $7.35 Billion to Settle Firefighting Foam Cancer Claims
Monsanto urged a Missouri judge to approve a proposed $7.25 billion Roundup settlement that could resolve nearly all current and future U.S. cancer claims against the company, telling the court there is no other negotiated deal waiting if the agreement falls apart.“This is the settlement,” Monsanto attorney James Bennett told... Read More about Monsanto Says $7.25 Billion Roundup Deal Is Its Only Settlement as 65,000 Cancer Claims Remain
During the 2 1/2 hour closing arguments in an ongoing opioid trial, brought by New York State and counties alleging the drugmaker Allergan flooded the state with opioids, the firm agreed to a $200 million settlement. The lawsuit was specifically against AbbVie Inc, a company that is part of Allergan,... Read More about $200 Million Opioid Settlement for Allergan in New York Follows Numerous Other Drug Firms That Already Settled for Over $1.5 Billion
A new $6.4 billion lawsuit against Bristol Myers Squibb Co (BMY.N) in Manhattan Federal Court accuses the firm of delaying lymphoma cancer drugs to avoid paying Celgene Corp's shareholders, avoiding a "milestone" payment. Bristol Myers Squibb, which purchased the drug manufacturer Celgene Corporation in 2019, was slapped with the lawsuit... Read More about Bristol-Myers Sued for $6.4 billion Due to Alleged Stalling of Cancer Drug to Avoid Payments to Celgene Shareholders.
The U.S. Supreme Court ruled Thursday that federal pesticide law bars a Missouri man’s failure-to-warn claim against Monsanto over Roundup, a decision that gives the company a major win in litigation over cancer warnings on the widely used weed killer.In a 7-2 decision, the Court reversed a Missouri appeals court... Read More about Supreme Court Blocks Roundup Cancer-Warning Claim Against Monsanto